Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lesley Fallowfield

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
BMJ (Clinical Research Ed.)|November 15, 2008
Recruitment to multicentre trials--lessons from UKCTOCS: descriptive studyUsha Menon, Aleksandra Gentry-Maharaj, Andy Ryan, et al.
British Journal of Cancer|September 30, 2024
BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trialBethany Torr, Christopher Jones, Grace Kavanaugh, et al.
BMJ Open|December 3, 2021
POSNOC-POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodesAmit Goyal, G Bruce Mann, Lesley Fallowfield, et al.
Journal of Medical Genetics|July 22, 2022
A digital pathway for genetic testing in UK NHS patients with cancer: BRCA-DIRECT randomised study internal pilotBethany Torr, Christopher Jones, Subin Choi, et al.
British Journal of Cancer|July 26, 2017
The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Usha Menon, Alistair J McGuire, Maria Raikou, et al.
Lancet (London, England)|May 15, 2021
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trialUsha Menon, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
The Lancet. Oncology|March 14, 2009
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Usha Menon, Aleksandra Gentry-Maharaj, Rachel Hallett, et al.
The Lancet. Oncology|December 15, 2010
Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohortIan Jacobs, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer ScreeningUsha Menon, Andy Ryan, Jatinderpal Kalsi, et al.
Lancet (London, England)|December 29, 2015
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trialIan J Jacobs, Usha Menon, Andy Ryan, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
BMJ (Clinical Research Ed.)|November 15, 2008
Recruitment to multicentre trials--lessons from UKCTOCS: descriptive studyUsha Menon, Aleksandra Gentry-Maharaj, Andy Ryan, et al.
British Journal of Cancer|September 30, 2024
BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trialBethany Torr, Christopher Jones, Grace Kavanaugh, et al.
BMJ Open|December 3, 2021
POSNOC-POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodesAmit Goyal, G Bruce Mann, Lesley Fallowfield, et al.
Journal of Medical Genetics|July 22, 2022
A digital pathway for genetic testing in UK NHS patients with cancer: BRCA-DIRECT randomised study internal pilotBethany Torr, Christopher Jones, Subin Choi, et al.
British Journal of Cancer|July 26, 2017
The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Usha Menon, Alistair J McGuire, Maria Raikou, et al.
Lancet (London, England)|May 15, 2021
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trialUsha Menon, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
The Lancet. Oncology|March 14, 2009
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Usha Menon, Aleksandra Gentry-Maharaj, Rachel Hallett, et al.
The Lancet. Oncology|December 15, 2010
Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohortIan Jacobs, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer ScreeningUsha Menon, Andy Ryan, Jatinderpal Kalsi, et al.
Lancet (London, England)|December 29, 2015
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trialIan J Jacobs, Usha Menon, Andy Ryan, et al.
Pageof 12